Hester Biosciences to receive Rs 60 crore grant from BIRAC for COVID vaccine manufacturing

Published On 2022-04-09 04:15 GMT   |   Update On 2022-04-09 13:00 GMT

New Delhi: Hester Biosciences on Thursday said it will receive a Rs 60-crore grant from Biotechnology Industry Research Assistance Council (BIRAC) to support COVID-19 vaccine manufacturing.

''The company's board has approved execution of grant-in-aid letter agreement for a grant of Rs 60 crore (in phased manner) to the drug maker by BIRAC under Mission COVID Suraksha,'' Hester Biosciences said in a regulatory filing.

Read also: Hester India to acquire 50 percent stake in Thrishool Exim for Rs 16 crore

Last year, a Memorandum of Understanding was inked between Bharat Biotech and Gujarat COVID Vaccine Consortium (GCVC) for the production of Covaxin.

GCVC comprises Gujarat Biotechnology Research Centre, Hester Biosciences and OmniBRx Biotechnologies.

Read also: Hester Biosciences Limited ventures into Pet Care Industry

Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.
 BIRAC is a industry-academia interface and implements its mandate through a wide range of impact initiatives, be it providing access to risk capital through targeted funding, technology transfer, IP management and handholding schemes that help bring innovation excellence to the biotech firms and make them globally competitive. In its Eight years of existence, BIRAC has initiated several schemes, networks and platforms that help to bridge the existing gaps in the industry-academia Innovation research and facilitate novel, high quality affordable products development through cutting edge technologies.
BIRAC has initiated partnerships with several national and global partners to collaborate and deliver the salient features of its mandate.
Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News